Evidence map›Paper›PMID 28693525›Full record

Trial reportReproductive health2017

Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi.

Monique van Lettow, Hannock Tweya, Nora E Rosenberg, Clement Trapence, Virginia Kayoyo, Florence Kasende, Blessings Kaunda, Mina C Hosseinipour, Michael Eliya, Fabian Cataldo and 3 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Reproductive health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02005835 (Improving Uptake and Retention in PMTCT Services Through Novel Approaches in Family Supported Care and in Community Peer Outreach Support in Malawi), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02005835 naunknown statusnot on this map

Improving Uptake and Retention in PMTCT Services Through Novel Approaches in Family Supported Care and in Community Peer Outreach Support in Malawi

TypeinterventionalSponsorLighthouse TrustRan2013 to 2016Enrolled1,050ConditionsHIVArmsCommunity based peer support, Facility-based Peer Support
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Monique van LettowDignitas International, Zomba, Malawi. m.vanlettow@dignitasinternational.org.
Hannock TweyaLighthouse Trust, Lilongwe, Malawi.
Nora E RosenbergUniversity of North Carolina Project, Lilongwe, Malawi.
Clement TrapenceLighthouse Trust, Lilongwe, Malawi.
Virginia KayoyoUniversity of North Carolina Project, Lilongwe, Malawi.
Florence KasendeDignitas International, Zomba, Malawi.
Blessings KaundaUniversity of Malawi, College of Medicine, Malaria Alert Centre, Blantyre, Malawi.
Mina C HosseinipourUniversity of North Carolina Project, Lilongwe, Malawi.
Michael EliyaDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
Fabian CataldoDignitas International, Zomba, Malawi.
Salem GugsaLighthouse Trust, Lilongwe, Malawi.
Sam PhiriLighthouse Trust, Lilongwe, Malawi.
PURE Malawi consortium

Funding

Developing and Assessing a Male Engagement Intervention for Option B+ in MalawiR00MH104154 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROSENBERG, NORA · 2017 to 2019
$746k
NIMH NIH HHS R00 MH104154
6 · The paper itself

Abstract

backgroundMalawi introduced an ambitious public health program known as "Option B+" which provides all HIV-infected pregnant and breastfeeding women with lifelong combination antiretroviral therapy, regardless of WHO clinical stage or CD4 cell count. The PMTCT Uptake and REtention (PURE) study aimed at evaluating the effect of peer-support on care-seeking and retention in care. METHODS/

designPURE Malawi was a three-arm cluster randomized controlled trial that compared facility-based and community-based models of peer support to standard of care under Option B+ strategy. Each arm was expected to enroll a minimum of 360 women with a total minimum sample size of 1080 participants. 21 sites (clusters) were selected for inclusion in the study. This paper describes the site selection, recruitment, enrollment process and baseline characteristics of study sites and women enrolled in the trial.

resultsStudy implementation was managed by 3 partner organizations; each responsible for 7 study sites. The trial was conducted in the South East, South West, and Central West zones of Malawi, the zones where the implementing partners operate. Study sites included 2 district hospitals, 2 mission hospitals, 2 rural hospitals, 13 health centers and 1 private clinic. Enrollment occurred from November 2013 to November 2014, over a median period of 31 weeks (range 17-51) by site. A total of 1269 HIV-infected pregnant (1094) and breastfeeding (175) women, who were eligible to initiate ART under Option B+, were enrolled. Each site reached or surpassed the minimum sample size. Comparing the number of women enrolled versus antenatal cohort reports, sites recruited a median of 90% (IQR 75-100) of eligible reported women. In the majority of sites the ratio of pregnant and lactating women enrolled in the study was similar to the ratio of reported pregnant and lactating women starting ART in the same sites. The median age of all women was 27 (IQR 22-31) years. All women have ≥20 months of possible follow-up time; 96% ≥ 2 years (24-32 months).

conclusionThe PURE Malawi study showed that 3 implementing partner organizations could successfully recruit a complex cohort of pregnant and lactating women across 3 geographical zones in Malawi within a reasonable timeline.

trial registrationThis study is registered at clinicaltrials.gov - ID Number NCT02005835 . Registered 4 December, 2013.

Indexed as

Public HealthSocial SupportAdultAnti-Retroviral AgentsFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalMalawiPregnancyPregnancy Complications, InfectiousAnti-Retroviral AgentsCluster randomized trialFeasibilityMalawiPeer-supportPMTCTRetentionUptake

Identifiers

PMID28693525
PMCPMC5504621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.